Respiratory measurement using infrared thermography and respiratory volume monitor during sedation in patients undergoing endoscopic urologic procedures under spinal anesthesia.

We aimed to evaluate changes in respiratory pattern after sedation by simultaneously applying a respiratory volume monitor (ExSpiron1Xi, RVM) and infrared thermography (IRT) to patients undergoing spinal anesthesia during endoscopic urologic surgeries. After spinal anesthesia was performed, the patient was placed in a lithotomy position for surgery. Then, we established the baseline of the RVM, and started monitoring the mouth and nose with the infrared camera. SpO2 was continuously measured throughout these processes. Once the baseline was set, 0.05 mg/kg midazolam was administered for sedation. Apnea was defined as cessation of airflow for ≥ 10 s with respiratory rate of < 6 breaths/min; hypopnea was defined as a decrease in oxygen hemoglobin of > 4%, compared to baseline. We measured the time at which apnea was detected by IRT, the time at which hypopnea was detected by RVM, and the time at which hypoxia was detected by SpO2. Twenty patients (age: 68.9 ± 11.2 years, body mass index: 24.2 ± 2.6 kg/min2) completed the study. Before sedation, the baseline correlation coefficient of respiratory rate detection between RVM and IRT was 0.866. After midazolam administration, apnea was detected in all subjects within the first 5 min by IRT; the median time required to detect apnea was 102.5 [interquartile range (IQR) 25-75%: 80-155] s. Hypopnea was detected in all subjects within the first 5 min by RVM: the median time required to detect hypopnea was 142.5 (IQR 115-185.2) s. The median time required for SpO2 to decrease > 4% from baseline was 160 (IQR 125-205) s. Our results suggest that IRT can be useful for rapid detection of respiratory changes in patients undergoing sedation following spinal anesthesia for endoscopic urologic procedures.

Does perioperative intravenous dextrose reduce postoperative nausea and vomiting? A systematic review and meta-analysis.

PURPOSE: Perioperative dextrose-containing fluid administration has been used as a non-pharmacologic preventive measure against postoperative nausea and vomiting (PONV), a common and distressing complication of anesthesia. However, its efficacy remains unclear as previous studies reported inconsistent results. Our objective was to compare dextrose-containing fluid with non-dextrose-containing fluid in terms of PONV for 24 hours after surgery under general anesthesia. The effects of dextrose according to different types of surgery and the fluid volume were also examined. METHODS: We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing dextrose-containing fluid with non-dextrose-containing fluids after general anesthesia in terms of PONV incidence and the need for rescue anti-emetic therapies for 24 hours after surgery. A literature search was performed, using Medline, EMBASE, Cochrane Central Register of Controlled Trials, Web of Science, and Scopus, up to February 2018. RESULTS: We included seven RCTs. Compared with the control group, perioperative dextrose administration did not reduce the risk for PONV, with a relative risk (RR) of 0.72 (95% CI: 0.50-1.03). However, perioperative dextrose reduced the requirement for anti-emetics, compared with the control group, with a RR of 0.60 (95% CI: 0.44-0.83). The quality of evidence in this meta-analysis was poor due to high risks of selection and performance biases and substantial statistical heterogeneity. After subgroup analysis, the risk for PONV was reduced in patients who had undergone laparoscopic cholecystectomy, but not other surgeries, and the effects of dextrose on the risk for PONV did not differ according to the fluid volume administered. CONCLUSION: Perioperative intravenous (i.v.) dextrose did not reduce the risk for PONV. However, it did reduce the need for anti-emetics after general anesthesia. Furthermore, the effects of dextrose varied according to the surgery type. Further studies are needed to determine the benefits of perioperative i.v. dextrose administration as a preventive measure against PONV.

The addition of capnography to standard monitoring reduces hypoxemic events during gastrointestinal endoscopic sedation: a systematic review and meta-analysis.

BACKGROUND: The use of capnography monitoring devices has been shown to lower the rates of hypoxemia via early detection of respiratory depression, and facilitate more accurate titration of sedatives during procedures. The aim of the current meta-analysis was to compare the incidence of hypoxemia associated with standard monitoring alone during gastrointestinal endoscopy to that associated with standard monitoring with the addition of capnography. METHODS: The MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials scientific databases were searched to identify relevant studies. We performed a meta-analysis of randomized controlled trials undertaken up to January 2018 that met our predefined inclusion criteria. The study outcome measures were incidence of hypoxemia, severe hypoxemia, apnea, the use of assisted ventilation, the use of supplemental oxygen, and change in vital signs. RESULTS: We included nine trials assessing a total of 3,088 patients who underwent gastrointestinal procedural sedation. Meta-analysis of study outcome revealed that capnography significantly reduced the incidence of hypoxemia (odds ratio 0.61, 95% CI 0.49-0.77) and severe hypoxemia (odds ratio 0.53, 95% CI 0.35-0.81). However, there were no significant differences in other outcomes including incidence of apnea, assisted ventilation, supplemental oxygen, and changes in vital signs. Early procedure termination and patient satisfaction-related outcomes did not differ significantly in the capnography group and the standard monitoring group. CONCLUSION: This study indicates that capnography monitoring is an important addition with regard to the detection of hypoxemia during gastrointestinal procedural sedation, and should be considered in routine monitoring during gastrointestinal endoscopy.